The Burke Neurological Institute (BNI) has received a five year award expected to total $45 million from the National Institutes of Health (NIH) to launch a large-scale, multi-center clinical trial to evaluate benfotiamine, a synthetic precursor of thiamine (vitamin B1), as a potentially effective therapy for mild Alzheimer’s disease (AD) or mild cognitive impairment (MCI).
February 11th is the International Day of Women and Girls in Science, a day that celebrates the contributions of women and girls in research globally. BNI promotes the next generation of neuroscientists through our educational programs for high school and college students.
As we celebrate and review our accomplishments of the year 2021, a spotlight shines on our strides taken towards advancing the study of neurological diseases and injuries.
"Decoding Stroke" is a new educational video series presented by Susan Wortman-Jutt and brought to you by the researchers, scientists and clinicians at the Burke Neurological Institute.
Faculty and staff of the Burke Neurological Institute (BNI) reunited in-person and remotely to attend a two-day Annual Retreat at the Minerals Resort and Spa at the Crystal Springs Resort.
Burke Neurological Institute (BNI) is deeply saddened by the passing of an incredibly kind and thoughtful colleague, Dr. M. Flint Beal. As one of the greatest clinician-scientists of his generation, Dr.
